Post-licensure rapid immunization safety monitoring program (PRISM) data characterization

Vaccine

Volumn 31, Issue S10, 2013, Pages

  Baker, Meghan A ^a,b   Nguyen, Michael ^c   Cole, David V ^a   Lee, Grace M ^a,d   Lieu, Tracy A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Data characterization; Health outcome; Mini Sentinel; PRISM; Surveillance; Vaccine

Indexed keywords

HEPATITIS B VACCINE; ROTAVIRUS VACCINE; VACCINE; VARICELLA ZOSTER VACCINE;

ALGORITHM; ARTICLE; DRUG APPROVAL; DRUG DATABASE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEPATITIS B; HERPES ZOSTER; HUMAN; ICD-9; IMMUNIZATION; INFECTION; INFECTION PREVENTION; PATIENT SAFETY; PRIORITY JOURNAL; REGISTER; ROTAVIRUS INFECTION;

CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; CODES FOR VACCINE ADMINISTERED; COMBINED TETANUS, DIPHTHERIA AND PERTUSSIS; COMMON PROCEDURAL TERMINOLOGY; CPT; CVX; DATA CHARACTERIZATION; DIPHTHERIA, TETANUS AND PERTUSSIS; DTAP; ED; EMERGENCY DEPARTMENT; FDA; FOOD AND DRUG ADMINISTRATION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH OUTCOME; HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET; HEDIS; HIB; HPV; HUMAN PAPILLOMAVIRUS (HPV); ICD; INACTIVATED POLIO VACCINE; INTERNATIONAL CLASSIFICATION OF DISEASES; IPV; MCV4; MEASLES, MUMPS AND RUBELLA; MENINGOCOCCAL CONJUGATE VACCINE; MINI-SENTINEL; MMR; NATIONAL IMMUNIZATION SURVEY; NIS; PCV; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; POST-LICENSURE RAPID IMMUNIZATION SAFETY MONITORING; PPV; PRISM; SURVEILLANCE; TD; TDAP; TETANUS AND DIPHTHERIA; VACCINE;

AUTOMATIC DATA PROCESSING; DATA COLLECTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; PRODUCT SURVEILLANCE, POSTMARKETING; SENTINEL SURVEILLANCE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION; VACCINES;

EID: 84891912067     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.088     Document Type: Article

References (81)

1. Salmon D., Yih W.K., Lee G., Rosofsky R., Brown J., Vannice K., et al. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood) 2012, 31(November (11)):2518-2527.
2. Nguyen M., Ball R., Midthun K., Lieu T.A. The food and drug administration's post-licensure rapid immunization safety monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf 2012, January (21)(Suppl. 1):291-297.
3. Curtis L.H., Weiner M.G., Boudreau D.M., Cooper W.O., Daniel G.W., Nair V.P., et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf 2012, January (21)(Suppl. 1):23-31.
4. National state, and local area vaccination coverage among children aged 19-35 months - United States, 2011. MMWR Morb Mortal Wkly Rep 2012, September (61):689-696.
5. Centers for Disease Control and Prevention, U.S. Vaccination Coverage Reported via NIS. [cited 09.10.12]; available from: http://www.cdc.gov/vaccines/stats-surv/nis/default.htm.
6. National Committee for Quality Assurance, Continuous improvement and the expansion of quality measurement 2011 [cited 09.10.12]; available from: http://www.ncqa.org/LinkClick.aspx%3Ffileticket=wmpxiKWVgP0%3d%26tabid=36.
7. Yih W.K., Lee G.M., Lieu T.A., Ball R., Kulldorff M., Rett M., et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009-2010. Am J Epidemiol 2012, 175(June (11)):1120-1128.
8. Lieu T.A., Nguyen M.D., Ball R., Martin D.B. Health outcomes of interest for evaluation in the post-licensure rapid immunization safety monitoring program. Vaccine 2012, 30(April (18)):2824-2830.
9. Yih K, Lieu T, Kulldorff M, Greene S, Belongia E, Nguyen M, et al. Monitoring for intussusception after two rotavirus vaccines by the PRISM program 2011 [cited 03.12.13]; available from: http://www.mini-sentinel.org/work_products/PRISM/Mini-Sentinel_PRISM_Rotavirus-Protocol.pdf.
10. Nguyen MD, Greene SK, Yih WK, Kulldorff M, Lieu TA, Selvam N, et al., Monitoring for venous thromboembolism after Gardasil vaccination [cited 03.12.13]; available from: http://www.mini-sentinel.org/work_products/PRISM/Mini-Sentinel_PRISM_Gardasil-and-Venous-Thromboembolism-Protocol.pdf.
11. Klein N.P., Ray P., Carpenter D., Hansen J., Lewis E., Fireman B., et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010, 28(January (4)):1062-1068.
12. Vanderloo S.E., Johnson J.A., Reimer K., McCrea P., Nuernberger K., Krueger H., et al. Validation of classification algorithms for childhood diabetes identified from administrative data. Pediatr Diab 2012, 13(May (3)):229-234.
13. Cirasino L., Robino A.M., Cattaneo M., Pioltelli P.E., Pogliani E.M., Terranova L., et al. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis. Blood Coagul Fibrinolysis 2010, 21(January (1)):77-84.
14. Glanz J., France E., Xu S., Hayes T., Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008, 121(March (3)):e506-e512.
15. Goodman M.J., Nordin J.D., Belongia E.A., Mullooly J.P., Baggs J. Henoch-Scholein purpura and polysaccharide meningococcal vaccine. Pediatrics 2010, 126(August (2)):e325-e329.
16. Verstraeten T., Davis R.L., DeStefano F., Lieu T.A., Rhodes P.H., Black S.B., et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112(November (5)):1039-1048.
17. Andrews N., Miller E., Grant A., Stowe J., Osborne V., Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics 2004, 114(September (3)):584-591.
18. Young H.A., Geier D.A., Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008, 271(August (1-2)):110-118.
19. Klein N.P., Fireman B., Yih W.K., Lewis E., Kulldorff M., Ray P., et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010, 126(July (1)):e1-e8.
20. Shui I.M., Shi P., Dutta-Linn M.M., Weintraub E.S., Hambidge S.J., Nordin J.D., et al. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine 2009, 27(August (39)):5307-5312.
21. Huang W.T., Gargiullo P.M., Broder K.R., Weintraub E.S., Iskander J.K., Klein N.P., et al. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics 2010, 126(August (2)):263-269.
22. Nakamura N., Nokura K., Zettsu T., Koga H., Tachi M., Terada M., et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med 2003, 42(February (2)):191-194.
23. McMahon A.W., Iskander J., Haber P., Chang S., Woo E.J., Braun M.M., et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics 2005, 115(February (2)):453-460.
24. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110(August (2)):105-123.
25. Haber P., DeStefano F., Angulo F.J., Iskander J., Shadomy S.V., Weintraub E., et al. Guillain-Barre syndrome following influenza vaccination. J Am Med Assoc 2004, 292(November (20)):2478-2481.
26. Juurlink D.N., Stukel T.A., Kwong J., Kopp A., McGeer A., Upshur R.E., et al. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006, 166(November (20)):2217-2221.
27. Bogliun G., Beghi E. Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome. Neurol Sci 2002, 23(September (3)):113-117.
28. Souayah N., Nasar A., Suri M.F., Qureshi A.I. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 2007, 25(July (29)):5253-5255.
29. Langmuir A.D., Bregman D.J., Kurland L.T., Nathanson N., Victor M. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984, 119(June (6)):841-879.
30. Greene S.K., Kulldorff M., Lewis E.M., Li R., Yin R., Weintraub E.S., et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol 2010, 171(January (2)):177-188.
31. Zhou W., Pool V., DeStefano F., Iskander J.K., Haber P., Chen R.T. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004, 13(August (8)):505-510.
32. Chou C.H., Liou W.P., Hu K.I., Loh C.H., Chou C.C., Chen Y.H. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007, 25(April (15)):2839-2841.
33. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350(February (9)):896-903.
34. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59(August (4)):499-505.
35. Lee G.M., Greene S.K., Weintraub E.S., Baggs J., Kulldorff M., Fireman B.H., et al. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med 2011, 41(August (2)):121-128.
36. VanLandingham M., Hanigan W., Vedanarayanan V., Fratkin J. An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children. Childs Nerv Syst 2010, 26(May (5)):655-661.
37. Sejvar J.J., Kohl K.S., Bilynsky R., Blumberg D., Cvetkovich T., Galama J., et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(August (31)):5771-5792.
38. Hull T.P., Bates J.H. Optic neuritis after influenza vaccination. Am J Ophthalmol 1997, 124(November (5)):703-704.
39. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004, 111(March (3)):491-500. [discussion].
40. Fraunfelder F.W., Suhler E.B., Fraunfelder F.T., Hepatitis B. vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 2010, 29(March (1)):26-29.
41. Debeer P., De Munter P., Bruyninckx F., Devlieger R. Brachial plexus neuritis following HPV vaccination. Vaccine 2008, 26(August (35)):4417-4419.
42. Kao K.L., Yeh S.J., Chen C.C. Myopericarditis associated with varicella zoster virus infection. Pediatr Cardiol 2010, 31(July (5)):703-706.
43. Belay E.D., Holman R.C., Clarke M.J., Destefano F., Shahriari A., Davis R.L., et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediat Infect Dis J 2000, 19(September (9)):828-832.
44. Holman R.C., Shahriari A., Effler P.V., Belay E.D., Schonberger L.B. Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut. Arch Pediatr Adolesc Med 2000, 154(August (8)):804-808.
45. Lin Y.T., Manlhiot C., Ching J.C., Han R.K., Nield L.E., Dillenburg R., et al. Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int 2010, 52(October (5)):699-706.
46. Miller R.L., Cheng M., DiMango E.A., Geromanos K., Rothman P.B. T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. Journal of Allergy and Clinical Immunology 2003, 112(September (3)):606-608.
47. Belongia E.A., Irving S.A., Shui I.M., Kulldorff M., Lewis E., Yin R., et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatric Infectious Disease Journal 2010, 29(January (1)):1-5.
48. Shui I.M., Baggs J., Patel M., Parashar U.D., Rett M., Belongia E.A., et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA: the Journal of the American Medical Association 2012, 307(February (6)):598-604.
49. Buttery J.P., Danchin M.H., Lee K.J., Carlin J.B., McIntyre P.B., Elliott E.J., et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011, 29(April (16)):3061-3066.
50. Schattner A., Ben-Chetrit E., Schmilovitz H. Poliovaccines and the course of systemic lupus erythematosus - a retrospective study of 73 patients. Vaccine 1992, 10(2):98-100.
51. Bernatsky S., Linehan T., Hanly J.G. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. Journal of Rheumatology 2011, 38(August (8)):1612-1616.
52. Bernatsky S., Lix L., Hanly J.G., Hudson M., Badley E., Peschken C., et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 2011, 31(April (4)):549-554.
53. Lin Y.C., Liang S.J., Liu Y.H., Hsu W.H., Shih C.M., Sung F.C., et al. Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatol Int 2012, 32(June (6)):1669-1673.
54. Chiu Y.M., Lai C.H. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 2010, 19(September (10)):1250-1255.
55. Singh J.A., Holmgren A.R., Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis and Rheumatism 2004, 51(December (6)):952-957.
56. Kim S.Y., Servi A., Polinski J.M., Mogun H., Weinblatt M.E., Katz J.N., et al. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Research Therapy 2011, 13(1):R32.
57. Ehrmann Feldman D., Bernatsky S., Houde M. The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study. Pediatric Rheumatology Online Journal 2009, 7:20.
58. Bohlke K., Davis R.L., Marcy S.M., Braun M.M., DeStefano F., Black S.B., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112(October (4)):815-820.
59. Coop C.A., Balanon S.K., White K.M., Whisman B.A., Rathkopf M.M. Anaphylaxis from the influenza virus vaccine. Int Arch Allergy Immunol 2008, 146(1):85-88.
60. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. J Am Med Assoc 2005, 294(December (21)):2720-2725.
61. Horowitz L. Urticaria subsequent to administration of influenza vaccine. South Med J 1979, 72(October (10)):1334-1335.
62. Centers for Disease Control and Prevention, Seasonal Influenza (Flu). [cited 11.14.12]; available from: http://www.cdc.gov/flu/professionals/vaccination/nfs-survey-march2012.htm.
63. Mayer-Davis E.J., Bell R.A., Dabelea D., D'Agostino R., Imperatore G., Lawrence J.M., et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009, 32(Suppl. 2):S99-S101. March.
64. 2011 National Diabetes Fact Sheet. [07.23.12]; Available from: http://www.cdc.gov/diabetes/pubs/references11.htm.
65. Gardner-Medwin J.M., Dolezalova P., Cummins C., Southwood T.R. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002, 360(October (9341)):1197-1202.
66. Lanzi G., Zambrino C.A., Termine C., Palestra M., Ferrari Ginevra O., Orcesi S., et al. Prevalence of tic disorders among primary school students in the city of Pavia, Italy. Arch Dis Child 2004, 89(January (1)):45-47.
67. Tse A., Tseng H.F., Greene S.K., Vellozzi C., Lee G.M. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 2012, 30(March (11)):2024-2031.
68. Verburgh M.E., Bruijnzeels M.A., van der Wouden J.C., van Suijlekom-Smit L.W., van der Velden J., Hoes A.W., et al. Incidence of febrile seizures in The Netherlands. Neuroepidemiology 1992, 11(4-6):169-172.
69. van Zeijl J.H., Mullaart R.A., Borm G.F., Galama J.M. Recurrence of febrile seizures in the respiratory season is associated with influenza A. J Pediatr 2004, 145(December (6)):800-805.
70. Black S., Eskola J., Siegrist C.A., Halsey N., Macdonald N., Law B., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009, 374(December (9707)):2115-2122.
71. Leake J.A., Albani S., Kao A.S., Senac M.O., Billman G.F., Nespeca M.P., et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004, 23(August (8)):756-764.
72. Rodriguez M., Siva A., Cross S.A., O'Brien P.C., Kurland L.T. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995, 45(February (2)):244-250.
73. Beghi E., Kurland L.T., Mulder D.W., Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol 1985, 18(September (3)):320-323.
74. MacDonald B.K., Cockerell O.C., Sander J.W., Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000, 123(April (Pt 4)):665-676.
75. Partinen M., Saarenpaa-Heikkila O., Ilveskoski I., Hublin C., Linna M., Olsen P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PloS ONE 2012, 7(3):e33723.
76. Becker S., Ejlertsen T., Kristensen B., Norgaard M., Nielsen H. Is the incidence of perimyocarditis increased following Campylobacter jejuni infection?. Eur J Clin Microbiol Infect Dis 2007, 26(December (12)):927-929.
77. Akinbami L.J., Moorman J.E., Bailey C., Zahran H.S., King M., Johnson C.A., et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012, 94(May):1-8.
78. Zickafoose J.S., Benneyworth B.D., Riebschleger M.P., Espinosa C.M., Davis M.M. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med 2012, 166(April (4)):350-355.
79. Gray R.H., Wu L.Y. Subfertility and risk of spontaneous abortion. Am J Public Health 2000, 90(September (9)):1452-1454.
80. MacDorman M.F., Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 2009, 57(January (8)):1-19.
81. Doran M.F., Pond G.R., Crowson C.S., O'Fallon W.M., Gabriel S.E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002, 46(March (3)):625-631.